CUE Cue Biopharma, Inc.
Price Chart
Executive Summary
Sumita Ray filed a Form 3 initial statement of beneficial ownership after becoming Chief Legal Compliance Officer and Corporate Secretary at Cue Biopharma. The filing discloses 54,589 shares of common stock and an option to purchase 109,179 shares at $30.42, vesting quarterly over four years from May 1, 2026. This is a routine insider onboarding filing with no material financial impact.
Actionable Insight
This is a standard Form 3 filing for a new officer. No trading signal. Monitor for future Form 4 filings if the insider begins open-market transactions.
Key Facts
- Sumita Ray appointed Chief Legal Compliance Officer and Corporate Secretary at Cue Biopharma.
- Reports beneficial ownership of 54,589 shares of common stock.
- Holds option to buy 109,179 shares at $30.42, vesting quarterly over four years from May 1, 2026.
- Form 3 filed on June 11, 2026, for event date June 1, 2026.
Financial Impact
No financial impact — routine insider onboarding filing with no transaction or material change.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001579629-26-000002 |
| Document: 0001579629-26-000002-index.html | 0001579629-26-000002 |
| Document: 0001579629-26-000002.txt | 0001579629-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
3
| $27.26 awaiting T+1 | awaiting T+1 | — | $24.53 (−10.01%) |
|
Jun 3, 2026
11d ago
|
S-3
| $29.64 $29.46 | ▲ +0.61% | ▼ −1.97% | $24.53 (+17.24%) |
|
Jun 2, 2026
12d ago
|
8-K
| $26.91 $29.64 | ▲ +10.14% | ▲ +9.75% | $24.53 (−8.84%) |
|
Apr 30, 2026
6w ago
|
Press Release
| $30.42 $29.85 | ▼ −1.87% | ▼ −1.53% | $24.53 (−19.36%) |
|
Apr 22, 2026
7w ago
|
8-K
| $17.40 $16.62 | ▼ −4.48% | ▼ −4.09% | $24.53 (+40.98%) |
|
Apr 8, 2026
9w ago
|
Press Release
| $8.22 $8.79 | ▲ +6.93% | ▲ +6.36% | $24.53 (+198.42%) |
|
Apr 7, 2026
9w ago
|
8-K
| $5.64 $8.22 | ▲ +45.74% | ▲ +43.21% | $24.53 (+334.93%) |
|
Apr 1, 2026
10w ago
|
EFFECT
| $6.09 $5.40 | ▲ +11.33% | ▲ +11.41% | $24.53 (−302.79%) |
|
Mar 27, 2026
11w ago
|
DEFA14A
| $6.78 $6.90 | ▲ +1.77% | ▼ −1.12% | $24.53 (+261.80%) |
|
Mar 27, 2026
11w ago
|
Press Release
| $6.78 $6.90 | ▲ +1.77% | ▼ −1.12% | $24.53 (+261.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access